Immunovaccine (IMV): Preparing to Cross the “Valley of Death” Harvard Case Solution & Analysis

The case describes the predicaments faced by Immunovaccine (IMV), a small biotechnology company founded in Halifax, Canada. The business has seen early success in the effectiveness of its technology in animal health and is searching for ways to manipulate the possibility of its technology more broadly and especially in human health.

The business's challenges are presented in the context of the evolving relationship between the biotechnology and pharmaceutical sectors. The case depicts a variety of issues the company face around 2008, shortly after the innovative president and CEO has taken over. It then offer details on strategy formulation and implementation under the novel CEO.

PUBLICATION DATE: October 13, 2010 PRODUCT #: 910M72-PDF-ENG

This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP

Immunovaccine (IMV): Preparing to Cross the “Valley of Death” Case Solution Other Similar Case Solutions like

Immunovaccine (IMV): Preparing to Cross the “Valley of Death”

Share This